OOIR: Observatory of International Research

Papers

(The H4-Index of European Journal of Endocrinology is 33. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)

Article	Citations
The 2021 European Group on Graves’ orbitopathy (EUGOGO) clinical practice guidelines for the medical management of Graves’ orbitopathy	425
MECHANISMS IN ENDOCRINOLOGY: Vitamin D and COVID-19	269
European Society of Endocrinology clinical practice guidelines on the management of adrenal incidentalomas, in collaboration with the European Network for the Study of Adrenal Tumors	139
GLOBAL ENDOCRINOLOGY: Global perspectives in endocrinology: coverage of iodized salt programs and iodine status in 2020	122
European expert consensus on practical management of specific aspects of parathyroid disorders in adults and in pregnancy: recommendations of the ESE Educational Program of Parathyroid Disorders (PARA	97
Efficacy and safety of larotrectinib in patients with TRK fusion-positive thyroid carcinoma	71
Increased COVID-19 infections in women with polycystic ovary syndrome: a population-based study	67
Recommendations from the 2023 international evidence-based guideline for the assessment and management of polycystic ovary syndrome	66
Endocrine-related adverse conditions in patients receiving immune checkpoint inhibition: an ESE clinical practice guideline	56
MANAGEMENT OF ENDOCRINE DISEASE: Thyroid and female infertility: more questions than answers?!	55
DIAGNOSIS OF ENDOCRINE DISEASE: Diagnosing and classifying diabetes in diseases of the exocrine pancreas	54
DIAGNOSIS OF ENDOCRINE DISEASE: Post-pancreatitis diabetes mellitus: prime time for secondary disease	53
ESE Clinical Practice Guideline on functioning and nonfunctioning pituitary adenomas in pregnancy	51
Safety of growth hormone replacement in survivors of cancer and intracranial and pituitary tumours: a consensus statement	50
S-GRAS score for prognostic classification of adrenocortical carcinoma: an international, multicenter ENSAT study	49
The spectrum of thyroid function tests during hospitalization for SARS COV-2 infection	49
Aggressive pituitary tumours and carcinomas, characteristics and management of 171 patients	46
Epidemiology of pheochromocytoma and paraganglioma: population-based cohort study	43
MANAGEMENT OF ENDOCRINE DISEASE: Gonadal dysfunction in congenital adrenal hyperplasia	42
Global epidemiology of acromegaly: a systematic review and meta-analysis	41
The interplay of thyroid hormones and the immune system – where we stand and why we need to know about it	41
Multiple testing: when is many too much?	41
More than a decade of real-world experience of pegvisomant for acromegaly: ACROSTUDY	40
Pubertal induction and transition to adult sex hormone replacement in patients with congenital pituitary or gonadal reproductive hormone deficiency: an Endo-ERN clinical practice guideline	40
Italian Association of Clinical Endocrinologists (AME) and International Chapter of Clinical Endocrinology (ICCE). Position statement for clinical practice: prolactin-secreting tumors	39

Immune checkpoint inhibitor therapy for ACTH-secreting pituitary carcinoma: a new emerging treatment?	38
Prevalence and outcome of dysnatremia in patients with COVID-19 compared to controls	37
Serum sodium alterations in SARS CoV-2 (COVID-19) infection: impact on patient outcome	37
Functional imaging with 11C-metomidate PET for subtype diagnosis in primary aldosteronism	36
Metformin use is associated with a lower risk of osteoporosis/vertebral fracture in Taiwanese patients with type 2 diabetes mellitus	35
MANAGEMENT OF ENDOCRINE DISEASE: Carney complex: clinical and genetic update 20 years after the identification of the CNC1 (PRKAR1A) gene	35
Corticotroph tumor progression after bilateral adrenalectomy (Nelson’s syndrome): systematic review and expert consensus recommendations	34
Conventional thyroidectomy vs thyroid thermal ablation on postoperative quality of life and satisfaction for patients with benign thyroid nodules	34
MECHANISMS IN ENDOCRINOLOGY: Local and systemic effects of glucocorticoids on metabolism: new lessons from animal models	33
DNAJC3 deficiency induces β-cell mitochondrial apoptosis and causes syndromic young-onset diabetes	33
MANAGEMENT OF ENDOCRINE DISEASE: Optimal feminizing hormone treatment in transgender people	33
MANAGEMENT OF ENDOCRINE DISEASE: Cardiovascular risk assessment, thromboembolism, and infection prevention in Cushing’s syndrome: a practical approach	33